Balance Sheet for ARCA biopharma Inc. (ABIO)

$ 6.69   0.26 (+4.04%) Volume: 795.82k 4:00 PM EDT Jul 8, 2020
After Hours:  $ 6.71   0.02 (+0.30%) Volume: 8.54k 6:41 PM EDT Jul 8, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 8,363 6,608 8,702 7,401 38,802
Restrictable Cash - - - - -
Marketable Securities - - 3,050 13,762 -
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses - - - - -
Current Deferred Income Taxes - - - - -
Other Current Assets 117 169 547 282 114
Total Current Assets 8,480 6,777 12,299 21,445 38,916
Land and Improvements - - - - -
Buildings and Improvement 59 59 59 59 8
Machinery, Furniture and Equipment 318 339 384 394 407
Construction in Progress - - - - -
Fixed Assets, Other 22 - - - -
Fixed Assets, Total 399 398 443 453 415
Gross Fixed Assets 399 398 443 453 415
Accumulated Depreciation (367) (374) (401) (387) (387)
Net Fixed Assets 32 24 42 66 28
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 24 24 24 766 630
Total Non-Current Assets 56 48 66 3,184 658
Total Assets 8,536 6,825 12,365 24,629 39,574
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 418 230 622 1,205 364
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses 379 413 691 472 471
Accrued Liabilities 379 413 691 472 471
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 129 150 757 719 669
Total Current Liabilities 926 793 2,070 2,396 1,504
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - - 20 39 -
Other Non-Current Liabilities - - 20 39 -
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - - 20 39 -
Total Liabilities 926 793 2,090 2,435 1,504
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 7,610 6,032 10,275 22,194 38,070
Common Par 2 1 12 9 9
Additional Paid in Capital 152,024 144,965 141,266 134,715 134,128
Cumulative Translation Adjustments - - - - -
Retained Earnings (144,416) (138,934) (131,001) (112,511) (96,067)
Treasury Stock - - - - -
Other Equity Adjustments - - (2) (19) -
Total Capitalization 7,610 6,032 10,275 22,194 38,070
Total Equity 7,610 6,032 10,275 22,194 38,070
Total Liabilities & Shareholder's Equity 8,536 6,825 12,365 24,629 39,574
Cash Flow (5,482) (7,957) (18,965) (16,925) (11,653)
Working Capital 7,554 5,984 10,229 19,049 37,412
Free Cash Flow (4,805) (8,248) (17,475) (14,999) (10,545)
Invested Capital 7,610 6,032 10,275 22,194 38,070
Shares Outstanding - Common Class Only 1,594 774 654 505 503
Preferred Shares Outstanding 25 25 25 25 25
Total Ordinary Shares 1,594 774 654 505 503
Total Common Shares Outstanding 1,594 774 654 505 503
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 1,321 769 580 504 349
Diluted Weighted Shares Outstanding 1,321 769 580 504 349